In the last century, the average human life expectancy doubled. Here’s a roadmap to the innovations that could help us do it again — maybe.
A compound known as alpha-ketoglutarate extends life span in female mice and health span in mice of both sexes. A trial is testing its effects on markers of aging in humans.
Obesity can take more than 10 years off life expectancy, and semaglutide, a drug that could soon be approved for weight loss, is about twice as effective as current medications.
Elamipretide, a drug that helps restore function to flagging mitochondria, the cells’ power plants, is awaiting F.D.A. approval as a treatment for a rare mitochondrial disease.
Maintaining widespread mask-wearing practices could result in a long-lasting drop in influenza deaths, which numbered 12,000 to 61,000 annually in the United States in the decade before the pandemic.
Further decoding and analyzing the genomes of those who live to be 110 or older could provide useful insights into what accounts for their longevity.
A bill in Congress targets, in part, a disparity in which Black women in the United States are about three times as likely as white women to die during the period including pregnancy, childbirth and the first year postpartum.
A compound similar to MOTS-c — a micropeptide that boosts physical fitness, prevents obesity and increases healthy life span in mice — is in human trials and could be approved within four years.
New ways to mobilize the immune system against cancer and fresh combinations of existing treatments will bring the immunotherapy revolution to a wider variety of hard-to-treat cancers.
Devices that stimulate the brain using specific frequencies of light and sound might help treat Alzheimer’s disease and other causes of cognitive decline.
Vaccines that exploit mRNA technology, which found proof of concept with Covid-19, are in the pipeline for melanomas, colorectal cancer, prostate cancer, breast cancer and more.
Respiratory infections kill some 750,000 children under age 5 each year. The W.H.O. and UNICEF hope to reach their target of fewer than three deaths per 1,000 births through vaccination, breastfeeding, access to quality health care and reduced pollution.
By Nicholas St. Fleur, Chloe Williams and Charlie Wood – April 27, 2021
In the dynamic landscape of dermatology research and development, Clinical Research Organizations (CROs) play a…
Explore Trends and Innovations at NYSCC To register, click here 📅 on Tuesday May…
Roger Guillemin identified the molecules in the brain that control the production of hormones in…